Specialty Pharma Journal Specialty, Precision & Technology
BOISE, Idaho, May 31, 2017 /PRNewswire/ — Albertsons Companies announced today that it recently acquired MedCart Specialty Pharmacy in order to strengthen and extend its pharmacy specialty services. MedCart Specialty Pharmacy is an industry-leading, URAC accredited, pharmaceutical and healthcare provider of customized specialty care services and medication management for patients …
Breaking News
- Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
- Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen
- FDA Grants Priority Review to Merck’s sBLA for Keytruda Monotherapy for Third-Line Treatment of Patients with Advanced SCLC
- Xencor Announces Partial Clinical Hold on Phase 1 Study of its Bispecific Antibody in Acute Myeloid Leukemia
- Takeda, Microsoft and EURORDIS Release Report with Action Plan to Help Rare Disease Community Shorten the Diagnostic Odyssey
- Merck’s Keytruda Fails to Meet Primary Endpoints in Phase 3 Study in Patients with Advanced Hepatocellular Carcinoma
- FDA Approves Novo Nordisk’s Esperoct for Treatment of Adults and Children with Hemophilia A
- Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials
- FDA Grants Priority Review to AbbVie’s Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
- Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency